195 related articles for article (PubMed ID: 33045385)
1. Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.
Dehn J; Chitphakdithai P; Shaw BE; McDonald AA; Devine SM; Burns LJ; Spellman S
Transplant Cell Ther; 2021 Feb; 27(2):184.e1-184.e13. PubMed ID: 33045385
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499
[TBL] [Abstract][Full Text] [Related]
3. Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.
Pidala J; Mupfudze TG; Payton T; Barker J; Perales MA; Shaw BE; Fernández-Viña M; Burns LJ; Dehn J
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2501-2506. PubMed ID: 31419569
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Opting Out of an Unrelated Hematopoietic Stem Cell Donor Registry: Differences and Similarities across Five Key Groups of Young Race/Ethnically Diverse Potential Donors in the United States.
Hamed AB; Bruce JG; Kuniyil V; Ahmed N; Mattila D; Williams EP; Dew MA; Myaskovsky L; Confer DL; Switzer GE
Transplant Cell Ther; 2024 May; 30(5):512.e1-512.e15. PubMed ID: 38365082
[TBL] [Abstract][Full Text] [Related]
5. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Arnold SD; Brazauskas R; He N; Li Y; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C; Hashmi S; Parsons S; Wood WA; Steinberg A; Freytes CO; Dandoy CE; Marks DI; Lazarus HM; Abdel-Azim H; Bitan M; Diaz MA; Olsson RF; Gergis U; Seber A; Wirk B; LeMaistre CF; Ustun C; Duncan C; Rizzieri D; Szwajcer D; Fagioli F; Frangoul H; Knight JM; Kamble RT; Mehta P; Schears R; Satwani P; Pulsipher MA; Aplenc R; Saber W
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1747-1756. PubMed ID: 32464284
[TBL] [Abstract][Full Text] [Related]
7. The National Marrow Donor Program: improving access to hematopoietic cell transplantation.
Walker T; Milford E; Chell J; Maiers M; Confer D
Clin Transpl; 2011; ():55-62. PubMed ID: 22755401
[TBL] [Abstract][Full Text] [Related]
8. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.
Gragert L; Eapen M; Williams E; Freeman J; Spellman S; Baitty R; Hartzman R; Rizzo JD; Horowitz M; Confer D; Maiers M
N Engl J Med; 2014 Jul; 371(4):339-48. PubMed ID: 25054717
[TBL] [Abstract][Full Text] [Related]
9. Chances of Finding Matched Unrelated Donors for Saudi Patients in Need of Hematopoietic Stem Cell Transplantation.
Jawdat D; Almutairi Y; Almutairi Z; Almusa A; Hajeer A
Transplant Cell Ther; 2021 May; 27(5):423.e1-423.e7. PubMed ID: 33781751
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely.
Olson JA; Gibbens Y; Tram K; Kempenich J; Novakovich J; Buck K; Dehn J
HLA; 2017 Feb; 89(2):77-81. PubMed ID: 28102042
[TBL] [Abstract][Full Text] [Related]
11. Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
Dubois V; Detrait M; Sobh M; Morisset S; Labussière H; Giannoli C; Nicolini F; Moskovtchenko P; Mialou V; Ducastelle S; Rey S; Thomas X; Barraco F; Tedone N; Marry E; Garnier F; Bertrand Y; Michallet M
Hum Immunol; 2016 Nov; 77(11):1008-1015. PubMed ID: 26902994
[TBL] [Abstract][Full Text] [Related]
12. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
13. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program.
Karanes C; Confer D; Walker T; Askren A; Keller C
Oncology (Williston Park); 2003 Aug; 17(8):1036-8, 1043-4, 1164-7. PubMed ID: 12966671
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
Buck K; Wadsworth K; Setterholm M; Maiers M; Confer D; Hartzman R; Schmidt A; Yang SY; Dehn J
Biol Blood Marrow Transplant; 2016 Apr; 22(4):759-763. PubMed ID: 26724431
[TBL] [Abstract][Full Text] [Related]
16. HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches.
Tozatto-Maio K; Torres MA; Degaide NHS; Cardoso JF; Volt F; Pinto ACS; Oliveira D; Elayoubi H; Kashima S; Loiseau P; Veelken H; Ferster A; Cappelli B; Rodrigues ES; Scigliuolo GM; Kenzey C; Ruggeri A; Rocha V; Simões BP; Tamouza R; Gluckman E
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2034-2039. PubMed ID: 32712327
[TBL] [Abstract][Full Text] [Related]
17. Impact of Ethnicity on Donor Search Results for Children Requiring Stem Cell Transplantation.
DiLabio J; Doyle J; Alexander S; Gupta S; Punnett A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e154-7. PubMed ID: 25333838
[TBL] [Abstract][Full Text] [Related]
18. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.
Confer D; Robinett P
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S3-S5. PubMed ID: 18724295
[TBL] [Abstract][Full Text] [Related]
19. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
20. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.
Dehn J; Spellman S; Hurley CK; Shaw BE; Barker JN; Burns LJ; Confer DL; Eapen M; Fernandez-Vina M; Hartzman R; Maiers M; Marino SR; Mueller C; Perales MA; Rajalingam R; Pidala J
Blood; 2019 Sep; 134(12):924-934. PubMed ID: 31292117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
